BiotechTube
Home/Pipeline/PulmoSIM Therapeutics Pipeline

PulmoSIM Therapeutics Pipeline

Not Specified

Pre-clinicalActive

Key Facts

Indication
Not Specified
Phase
Pre-clinical
Status
Active
Company
VeriSIM Life

About VeriSIM Life

VeriSIM Life is a private, AI-driven drug development company founded in 2017. It has developed the BIOiSIM platform, a sophisticated computational engine that integrates chemical and biological modeling with AI to generate a Translational Index™, predicting a drug candidate's likelihood of clinical success. The company operates a hybrid business model, offering its platform as a service to partners and also advancing its own pipeline of assets through its PulmoSIM Therapeutics brand. Recent industry awards and recognition indicate growing validation of its innovative approach to solving translational challenges.

View full company profile

Other Not Specified Drugs

DrugCompanyPhase
FL116Forlong BiotechnologyNot specified
FL117Forlong BiotechnologyNot specified
FL118Forlong BiotechnologyNot specified
FL301Forlong BiotechnologyNot specified
JSKN016AlphaMab OncologyPhase 1
JSKN033AlphaMab OncologyPhase 1
JSKN022AlphaMab OncologyPhase 1
JSKN027AlphaMab OncologyPhase 1
KN019AlphaMab OncologyPhase 1
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
SR2162SIMR (Australia) BiotechIND Approved